Overview
- 47 inspections across 46 sites are on record.
- 134 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2026-04-24.
At a glance
Inspections
47
Sites
46
Observations
134
Career since
Jun 2021
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Jiangsu Hansoh Pharmaceutical Group Co., Ltd | 24 Apr 2026 | Human Drugs | On file |
| Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site) | 15 Apr 2026 | Human Drugs | On file |
| CooperSurgical, Inc. | 24 Mar 2026 | Medical Devices & Rad Health | On file |
| Isteka | 29 Jan 2026 | Animal Drugs & Feeds | On file |
| Excel Vision | 22 Jan 2026 | Human Drugs | View 483 → |
Sites inspected
Jiangsu Hansoh Pharmaceutical Group Co., LtdLianyungang, China1 insp.
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Jinqiao Road Site)Lianyungang, China1 insp.
CooperSurgical, Inc.North Tonawanda, United States1 insp.
IstekaReykjavik, Iceland1 insp.
Excel VisionAnnonay, France1 insp.
Co-investigators
Investigators who share inspections with this person.
Brandy N Lepage4 shared
Justin A Boyd3 shared
Karishma G Gopaul3 shared
Dorothy P Kramer3 shared
Lillian S Wu3 shared
Junho Pak3 shared
Sandra A Boyd2 shared
Ofuje D Daniyan2 shared
Vivin George2 shared
Evan Tong2 shared
Full investigator report
Get the verbatim findings behind Karen A Briggs' 134 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site